Hosted on MSN22h
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead
Robotic surgery used to be fodder for science fiction movies. Not anymore. They are becoming more mainstream by the day.
Becker's Spine Review2d
How well-positioned is Zimmer Biomet for 2025?
Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.
IPWatchdog2d
SCOTUS Denies Petition Challenging Post-Patent Expiration Royalty Obligations Upheld in Arbitration
Yesterday, the U.S. Supreme Court (SCOTUS) denied the petition for writ of certiorari filed in Zimmer Biomet Holdings, Inc. v ...
ZBH Stock Might Rise Following FDA Nod for Knee Implant Component
Zimmer Biomet's Persona SoluTion Porous Plasma Spray Femur gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.
FierceBiotech8d
Zimmer Biomet's knee implants collect FDA green lights as cementless alternatives
Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who ...
MassDevice8d
Zimmer Biomet wins FDA nod for new total knee component
Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Persona SoluTion porous plasma spray ...
Zimmer announces FDA clearance of Persona SoluTion Porous Plasma Spray Femur
Holdings announced FDA clearance of Persona SoluTion Porous Plasma Spray Femur, a total knee implant component offering an ...
Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® SoluTion™ Porous Plasma Spray ...
Zacks.com on MSN16d
ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee
Premarket Approval Application (“PMA”) Supplement approval for the Oxford Cementless Partial Knee. The approval is based on ...